April 23rd 2025
The investment will be done over five years and will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple US states.
NGS abbreviates drug discovery timelines.
Drug Delivery Systems for Biopharmaceuticals
August 1st 2015Industry experts spoke to BioPharm International about the key considerations in the development of a drug-delivery device for a biologic drug, the importance of human factors engineering, the advantages of prefilled syringes, and the challenges in the manufacture of these devices.